Special Issue "Alliance of PET/SPECT Imaging and Drug Design/Discovery for the Development of Novel Diagnostic or Therapeutic Tools"
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 18226
Interests: radiochemistry; PET/SPECT imaging; targeted radionuclide therapy; medicinal chemistry; oncology
PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) imaging are essential scintigraphic techniques that can provide important in vivo functional information related to not only disease diagnosis but also treatment planning and follow up of patients. These imaging modalities are powerful tools for the evaluation and validation, at the preclinical and clinical levels, of new biological targets and innovative (radio)pharmaceutical compounds, coming from drug design/discovery studies. We also would like to point out the value of medicinal chemistry in the successful development of novel radiopharmaceuticals suitable for SPECT or PET imaging applications in nuclear medicine but also for theranostic approaches depending on the radionuclide introduced on the chemical scaffold considered.
In summary, this Special Issue aims to highlight and valorize the interactions between PET and SPECT imaging modalities and the drug design/discovery domains for the development of new diagnostic tools or (radio)therapeutic agents.
Dr. Aurélie Maisonial-Besset
Dr. Fabien Caillé
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- PET/SPECT imaging
- drug discovery
- drug design
- disease diagnosis
- theranostic approaches